Literature DB >> 25280635

Patient with spinal muscular atrophy with respiratory distress type 1 presenting initially with hypertonia.

Chunxi Han1, Jiahui Mai2, Tian Tian3, Yanxia He4, Jianxiang Liao1, Feiqiu Wen1, Xin Yi3, Yun Yang5.   

Abstract

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare autosomal recessive neuromuscular disorder caused by mutations in the IGHMBP2 gene and characterized by life-threatening respiratory distress due to irreversible diaphragmatic paralysis between 6weeks and 6months of age. In this study, we describe a two-month-old boy who presented with hypertonia at first and developed to hypotonia progressively, which was in contrast to the manifestations reported previously. Bone tissue compromise was also observed as one of the unique symptoms. Muscle biopsy indicated mild myogenic changes. He was misdiagnosed until genetic screening to be confirmed as SMARD1. SMARD1 is a clinical heterogeneous disease and this case broadens our perception of its phenotypes.
Copyright © 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone tissue compromise; Diaphragmatic paralysis; Hypertonia; IGHMBP2; Spinal muscular atrophy with respiratory distress type 1 (SMARD1)

Mesh:

Substances:

Year:  2014        PMID: 25280635     DOI: 10.1016/j.braindev.2014.09.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

1.  Diagnostic Odyssey and Application of Targeted Exome Sequencing in the Investigation of Recurrent Infant Deaths in a Syrian Consanguineous Family: a Case of Spinal Muscular Atrophy with Respiratory Distress Type 1.

Authors:  Young A Kim; Hye Young Jin; Yoo-Mi Kim
Journal:  J Korean Med Sci       Date:  2019-02-07       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.